<DOC>
	<DOCNO>NCT00446589</DOCNO>
	<brief_summary>Hemodialysis patient low bone density ( total hip T-score &lt; -2.5 ) assign receive teriparatide ( histologic confirmation adynamic bone disease ) ibandronate ( subject increase osteoclast number bone biopsy ) . Follow-up period : one year . A second bone biopsy end study .</brief_summary>
	<brief_title>The Effects Ibandronate Teriparatide Therapy Bone Histology Biochemical Indices Patients Hemodialysis With Low Bone Mineral Density</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Ibandronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Bone mineral density ( Tscore &lt; 2.5 ) Adynamic bone disease teriparatide group Increased osteoclast number bone biopsy ( high turnover ) ibandronate group Calcium great 8.1 mg/dl Suspected carcinoma Unstable clinical setting</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>